Anavex Life Sciences Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Anavex Life Sciences Corp.

Anavex Life Sciences Corp. | Key People and Executives

Christopher U. Missling

President, CEO, Secretary & Director

Claus van der Velden

Director

Peter Donhauser

Independent Director

Athanasios Skarpelos

Independent Director

Steffen Thomas

Independent Director

Elliot J. Favus

Independent Director

Bernd Metzner

Independent Director

Christopher U. Missling

President, CEO, Secretary & Director

Stephan Toutain

Senior Vice President-Operations

Emmanuel O. Fadiran

Senior Vice President-Regulatory Affairs

Ulrich Elben

Vice President-Preclinical Operations

Tasos Zografidis

Vice President-Clinical Operations

Claus van der Velden

Director

Peter Donhauser

Independent Director

Athanasios Skarpelos

Independent Director

Steffen Thomas

Independent Director

Elliot J. Favus

Independent Director

Bernd Metzner

Independent Director

View Profile

Address	51 West 52nd Street New York New York 10019 United States
Employees	-
Website	http://www.anavex.com
Updated	07/08/2019
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.